celastrol has been researched along with Vascular Calcification in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Kong, X; Lu, Y; Shen, Y; Sheng, Y; Su, Z; Sun, W; Yang, C; Yang, S; Zong, P | 1 |
| Chen, A; Dong, Q; Fu, M; Lan, Z; Li, Y; Liang, Q; Liu, X; Lu, L; Ou, JS; Wang, S; Yan, J; Yang, X; Ye, Y | 1 |
2 other study(ies) available for celastrol and Vascular Calcification
| Article | Year |
|---|---|
Celastrol attenuates arterial and valvular calcification via inhibiting BMP2/Smad1/5 signalling.
Topics: Animals; Aorta; Aortic Valve; beta Catenin; Bone Morphogenetic Protein 2; Calcium; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pentacyclic Triterpenes; Signal Transduction; Smad1 Protein; Smad5 Protein; Swine; Vascular Calcification; Vitamin D | 2020 |
Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney disease.
Topics: Animals; Cells, Cultured; Heme Oxygenase-1; Humans; Mice; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Osteogenesis; Oxidative Stress; Pentacyclic Triterpenes; Rats; Renal Insufficiency, Chronic; Up-Regulation; Vascular Calcification; X-Ray Microtomography | 2021 |